📰 Daniel Teper News
Page 2 - Daniel Teper News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Daniel Teper. Real-time updates on events, politics, business and more.
September 26, 2023
Press Release Crossject reports financial results and business highlights for first half of 2023 Strong progress in bringing drugs for use in emergency situations towards the market ...
September 26, 2023
Press Release Crossject reports financial results and business highlights for first half of 2023 Strong progress in bringing drugs for use in...
December 9, 2022
/PRNewswire/ -- Cytovia Inc.(DBA Cytovia Therapeutics, Inc.), a biopharmaceutical company focused on unlocking the power of natural killer (NK) cell...
November 8, 2022
Cytovia Therapeutics Presents New Data on TALEN® Gene-Edited iNK Cells and GPC3-Targeted Flex-NK™ Bispecific Antibodies at 2022 SITC Annual Meeting - read this article along with other careers information, tips and advice on BioSpace
November 7, 2022
AVENTURA, Fla. and NATICK, Mass., Nov. 7, 2022 /PRNewswire/ -- Cytovia Therapeutics, Inc., a biopharmaceutical company empowering natural killer ...
September 6, 2022
/PRNewswire/ -- Cytovia Therapeutics, Inc. today released the following statement on the passing of Olivier Gouédard, PharmD, MBA, who served as its Chief...
July 4, 2022
The number of fintech firms has more than doubled between 2017 and 2021, according to KPMG, but firms are being stymied by recruitment difficulties in the local market.
June 30, 2022
KPMG has shared its evaluation of the local fintech industry. The shifting market environment may threaten the efforts of Australia’s growing fintech sector to raise capital and recruit talent thro
April 8, 2022
/PRNewswire/ -- Cytovia Therapeutics, Inc., a biopharmaceutical company empowering natural killer (NK) cells to fight cancer through stem cell engineering and...
May 5, 2021
Cytovia Therapeutics Files New Patents for its Natural Killer Cell Engager Multifunctional Antibodies (FLEX-NK®) for the Treatment of Hematological and Solid Tumors First-in-class NK Engager multifunctional antibody products can activate patients’ own NK cells or be combined with Cytovia’s off-the-shelf Universal iPSC-derived NK Cells April 12, 2021 11:11 ET | Source: Cytovia Therapeutics Cytovia Therapeutics Miami, Florida, UNITED STATES CAMBR...